© Reuters Biogen (BIIB) gains as analysts reflect positively on Leqembi’s approval, pricing By Senad Karaahmetovic On Friday, the United States Food and Drug Administration (FDA) officially approved Leqembi, a new drug developed by Biogen (NASDAQ:) […]
Joe Raedle/Getty Images News Energy Transfer (NYSE:ET) has had an impressive, if almost a boring year. For me as an investor, boring is great, as ET has mostly disappeared from headlines as controversial projects have […]
© Reuters. Stellantis (STLA) signs deal with Element 25 for battery materials By Michael Elkins Stellantis NV (NYSE:), alongside Australian miner Element 25 (ASX:), announced Monday that the two companies have signed a deal for […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.